Atsuya Miki1, Felipe A Medeiros2, Robert N Weinreb2, Sonia Jain3, Feng He3, Lucie Sharpsten2, Naira Khachatryan2, Na'ama Hammel2, Jeffrey M Liebmann4, Christopher A Girkin5, Pamela A Sample2, Linda M Zangwill6. 1. Hamilton Glaucoma Center, Department of Ophthalmology, University of California, San Diego, La Jolla, California; Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. 2. Hamilton Glaucoma Center, Department of Ophthalmology, University of California, San Diego, La Jolla, California. 3. Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California. 4. Department of Ophthalmology, New York University School of Medicine, New York, New York; Department of Ophthalmology, Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York. 5. Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, Alabama. 6. Hamilton Glaucoma Center, Department of Ophthalmology, University of California, San Diego, La Jolla, California. Electronic address: lzangwill@ucsd.edu.
Abstract
PURPOSE: To compare the rates of retinal nerve fiber layer (RNFL) loss in patients suspected of having glaucoma who developed visual field damage (VFD) with those who did not develop VFD and to determine whether the rate of RNFL loss can be used to predict the development of VFD. DESIGN: Prospective, observational cohort study. PARTICIPANTS: Glaucoma suspects, defined as having glaucomatous optic neuropathy or ocular hypertension (intraocular pressure, >21 mmHg) without repeatable VFD at baseline, from the Diagnostic Innovations in Glaucoma Study and the African Descent and Glaucoma Evaluation Study. METHODS: Global and quadrant RNFL thickness (RNFLT) were measured with the Spectralis spectral-domain optical coherence tomography (SD-OCT; Spectralis HRA+OCT [Heidelberg Engineering, Heidelberg, Germany]). Visual field damage was defined as having 3 consecutive abnormal visual fields. The rate of RNFL loss in eyes developing VFD was compared to eyes not developing VFD using multivariate linear mixed-effects models. A joint longitudinal survival model used the estimated RNFLT slope to predict the risk of developing VFD, while adjusting for potential confounding variables. MAIN OUTCOME MEASURES: The rate of RNFL thinning and the probability of developing VFD. RESULTS: Four hundred fifty-four eyes of 294 glaucoma suspects were included. The average number of SD-OCT examinations was 4.6 (range, 2-9), with median follow-up of 2.2 years (0.4-4.1 years). Forty eyes (8.8%) developed VFD. The estimated mean rate of global RNFL loss was significantly faster in eyes that developed VFD compared with eyes that did not develop VFD (-2.02 μm/year vs. -0.82 μm/year; P<0.001). The joint longitudinal survival model showed that each 1-μm/year faster rate of global RNFL loss corresponded to a 2.05-times higher risk of developing VFD (hazard ratio, 2.05; 95% confidence interval, 1.14-3.71; P = 0.017). CONCLUSIONS: The rate of global RNFL loss was more than twice as fast in eyes that developed VFD compared with eyes that did not develop VFD. A joint longitudinal survival model showed that a 1-μm/year faster rate of RNFLT loss corresponded to a 2.05-times higher risk of developing VFD. These results suggest that measuring the rate of SD-OCT RNFL loss may be a useful tool to help identify patients who are at a high risk of developing visual field loss.
PURPOSE: To compare the rates of retinal nerve fiber layer (RNFL) loss in patients suspected of having glaucoma who developed visual field damage (VFD) with those who did not develop VFD and to determine whether the rate of RNFL loss can be used to predict the development of VFD. DESIGN: Prospective, observational cohort study. PARTICIPANTS: Glaucoma suspects, defined as having glaucomatous optic neuropathy or ocular hypertension (intraocular pressure, >21 mmHg) without repeatable VFD at baseline, from the Diagnostic Innovations in Glaucoma Study and the African Descent and Glaucoma Evaluation Study. METHODS: Global and quadrant RNFL thickness (RNFLT) were measured with the Spectralis spectral-domain optical coherence tomography (SD-OCT; Spectralis HRA+OCT [Heidelberg Engineering, Heidelberg, Germany]). Visual field damage was defined as having 3 consecutive abnormal visual fields. The rate of RNFL loss in eyes developing VFD was compared to eyes not developing VFD using multivariate linear mixed-effects models. A joint longitudinal survival model used the estimated RNFLT slope to predict the risk of developing VFD, while adjusting for potential confounding variables. MAIN OUTCOME MEASURES: The rate of RNFL thinning and the probability of developing VFD. RESULTS: Four hundred fifty-four eyes of 294 glaucoma suspects were included. The average number of SD-OCT examinations was 4.6 (range, 2-9), with median follow-up of 2.2 years (0.4-4.1 years). Forty eyes (8.8%) developed VFD. The estimated mean rate of global RNFL loss was significantly faster in eyes that developed VFD compared with eyes that did not develop VFD (-2.02 μm/year vs. -0.82 μm/year; P<0.001). The joint longitudinal survival model showed that each 1-μm/year faster rate of global RNFL loss corresponded to a 2.05-times higher risk of developing VFD (hazard ratio, 2.05; 95% confidence interval, 1.14-3.71; P = 0.017). CONCLUSIONS: The rate of global RNFL loss was more than twice as fast in eyes that developed VFD compared with eyes that did not develop VFD. A joint longitudinal survival model showed that a 1-μm/year faster rate of RNFLT loss corresponded to a 2.05-times higher risk of developing VFD. These results suggest that measuring the rate of SD-OCT RNFL loss may be a useful tool to help identify patients who are at a high risk of developing visual field loss.
Authors: Eun Ji Lee; Tae-Woo Kim; Robert N Weinreb; Ki Ho Park; Seok Hwan Kim; Dong Myung Kim Journal: Invest Ophthalmol Vis Sci Date: 2011-02-28 Impact factor: 4.799
Authors: Christopher K S Leung; Marco Yu; Robert N Weinreb; Cong Ye; Shu Liu; Gilda Lai; Dennis S C Lam Journal: Ophthalmology Date: 2012-01-20 Impact factor: 12.079
Authors: Christopher Kai-Shun Leung; Marco Yu; Robert N Weinreb; Gilda Lai; Guihua Xu; Dennis Shun-Chiu Lam Journal: Ophthalmology Date: 2012-06-05 Impact factor: 12.079
Authors: Christopher Kai Shun Leung; Shu Liu; Robert N Weinreb; Gilda Lai; Cong Ye; Carol Yim Lui Cheung; Chi Pui Pang; Kwok Kay Tse; Dennis Shun Chiu Lam Journal: Ophthalmology Date: 2011-04-29 Impact factor: 12.079
Authors: Christopher Kai-Shun Leung; Vivian Chiu; Robert N Weinreb; Shu Liu; Cong Ye; Marco Yu; Carol Yim-Lui Cheung; Gilda Lai; Dennis Shun-Chiu Lam Journal: Ophthalmology Date: 2011-04-29 Impact factor: 12.079
Authors: Vittorio Porciatti; William J Feuer; Pedro Monsalve; Giacinto Triolo; Luis Vazquez; John McSoley; Lori M Ventura Journal: J Glaucoma Date: 2017-05 Impact factor: 2.503
Authors: Jane Z Kuo; Linda M Zangwill; Felipe A Medeiros; Jeffery M Liebmann; Christopher A Girkin; Na'ama Hammel; Jerome I Rotter; Robert N Weinreb Journal: Am J Ophthalmol Date: 2015-04-04 Impact factor: 5.258
Authors: Sripad Krishna Devalla; Prajwal K Renukanand; Bharathwaj K Sreedhar; Giridhar Subramanian; Liang Zhang; Shamira Perera; Jean-Martial Mari; Khai Sing Chin; Tin A Tun; Nicholas G Strouthidis; Tin Aung; Alexandre H Thiéry; Michaël J A Girard Journal: Biomed Opt Express Date: 2018-06-25 Impact factor: 3.732
Authors: Lee M Jampol; Isoken Odia; Adam R Glassman; Carl W Baker; Anjali M Bhorade; Dennis P Han; Glenn J Jaffe; Michele Melia; Neil M Bressler; Angelo P Tanna Journal: Retina Date: 2019-01 Impact factor: 4.256
Authors: Huiyuan Hou; Sasan Moghimi; Linda M Zangwill; James A Proudfoot; Tadamichi Akagi; Takuhei Shoji; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Ophthalmol Glaucoma Date: 2019-11-14
Authors: Ting Liu; Andrew J Tatham; Carolina P B Gracitelli; Linda M Zangwill; Robert N Weinreb; Felipe A Medeiros Journal: Ophthalmology Date: 2015-09-15 Impact factor: 12.079